British Columbia Investment Management Corp Bio Techne Corp Transaction History

British Columbia Investment Management Corp

$16.2 Billion
Q2 2025

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$58.47 - $78.75 $409 - $551	7 Added 0.02%	30,396 $1.78 Million
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $270,922 - $319,089	4,082 Added 15.52%	30,389 $2.19 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $270,712 - $314,165	-3,815 Reduced 12.67%	26,307 $2.1 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $706,366 - $956,869	11,371 Added 60.64%	30,122 $2.16 Million
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $35,893 - $41,936	544 Added 2.99%	18,751 $1.32 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $212,852 - $315,148	4,029 Added 28.42%	18,207 $1.4 Million
Q2 2023 Aug 11, 2023	BUY	$73.76 - $85.98 $26,553 - $30,952	360 Added 2.61%	14,178 $1.16 Million
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $803,634 - $3.51 Million	9,962 Added 258.35%	13,818 $1.15 Million
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $194,387 - $269,592	-688 Reduced 15.14%	3,856 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $491,103 - $684,367	-1,522 Reduced 25.09%	4,544 $1.58 Million
Q1 2022 May 12, 2022	SELL	$353.85 - $487.79 $278,479 - $383,890	-787 Reduced 11.48%	6,066 $2.63 Million
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $159,652 - $183,770	-350 Reduced 4.86%	6,853 $3.55 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $18,684 - $22,632	-42 Reduced 0.58%	7,203 $3.49 Million
Q2 2021 Aug 09, 2021	BUY	$387.35 - $450.26 $2.81 Million - $3.26 Million	7,245 New	7,245 $3.26 Million

Others Institutions Holding TECH

# of Institutions

613

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.02B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account